Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $126.11 USD
Change Today -0.51 / -0.40%
Volume 61.0K
TFX On Other Exchanges
New York
As of 2:54 PM 10/13/15 All times are local (Market data is delayed by at least 15 minutes).

teleflex inc (TFX) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/29/15 - $140.50
52 Week Low
10/15/14 - $101.95
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TELEFLEX INC (TFX)

Related News

No related news articles were found.

teleflex inc (TFX) Related Businessweek News

No Related Businessweek News Found

teleflex inc (TFX) Details

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products for critical care therapies, including the administration of intravenous medications and other therapies, the measurement of blood pressure, and taking of blood samples through a single puncture site; and anesthesia products, such as airway management products under the LMA and Rusch brands, and pain management products under the Arrow brand. The company also provides respiratory care products, such as oxygen therapy, aerosol therapy, spirometry, and ventilation management products under the Hudson RCI brand. In addition, it offers surgical products, such as ligation clips and closure products; appliers and sutures used in surgical procedures; access ports for use in minimally invasive laparoscopic surgical procedures; robotic surgery and fluid management products for use in chest drainage; and reusable hand-held instruments for surgical procedures under the Deknatel, Pilling, Pleur-evac, Taut, and Weck brands. Further, the company offers cardiac care products comprising diagnostic catheters, including thermodilution and wedge pressure catheters; specialized catheters; therapeutic delivery catheters; sheaths for femoral and trans-radial aortic access, and intra-aortic balloons; and capital equipment, such as intra-aortic balloon pumps under the Arrow brand. Additionally, it provides catheters, urine collectors, catheterization accessories, and products for operative endourology under the Rusch brand name; micro-laparoscopic instrumentation products; and original equipment manufacturing services. The company offers its products to hospitals and healthcare providers through its direct sales force and distributors. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.

11,700 Employees
Last Reported Date: 02/20/15
Founded in 1943

teleflex inc (TFX) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $866.7K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $468.6K
Chief Operating Officer, Executive Vice Presi...
Total Annual Compensation: $431.5K
Senior Vice President of Global Operations
Total Annual Compensation: $312.2K
Vice President of Global Human Resources
Total Annual Compensation: $281.8K
Compensation as of Fiscal Year 2014.

teleflex inc (TFX) Key Developments

Teleflex to Showcase Arrow Endurance Extended Dwell Peripheral Catheter System at Ava 2015 Meeting in Dallas

Teleflex Incorporated announced that it will showcase its new Arrow Endurance Extended Dwell Peripheral Catheter System at the 29th Annual Scientific Meeting of the Association for Vascular Access, in Dallas, Texas, to be held Sept. 26-29, 2015. The Arrow Endurance System will be discussed at a Platinum Showcase titled “The New Age of Midlines and the Arrow Endurance Extended Dwell Peripheral Catheter System”, presented by Nancy Moureau, BSN, RN, CRNI, CPUI, VA-BC. The event will be held, Sept. 28 from 4:50 p.m. to 5:50 p.m. in room Grapevine A. The Arrow Endurance System is cleared by the FDA to dwell up to 29 days. The Arrow Endurance System enables hospitals to avoid using multiple peripheral IVs to achieve longer dwell times while also avoiding the extra clinical risks and expenses associated with a peripherally inserted central catheter (PICC). The Arrow Endurance Catheter is intended for short-term use to permit delivery of infusion therapies, pressure monitoring, high pressure injection (325 psi max.), and withdrawal of blood.

Teleflex Incorporated Presents at The Redefining Early Stage Investments (RESI) Conference 2015, Sep-16-2015 11:00 AM

Teleflex Incorporated Presents at The Redefining Early Stage Investments (RESI) Conference 2015, Sep-16-2015 11:00 AM. Venue: Boston, Massachusetts, United States. Speakers: Gwendolyn A. Watanabe, Vice President of Business Development and Technical Resources.

Teleflex Incorporated Receives FDA Clearance for ARROW® Triple Lumen Pressure Injectable Acute Hemodialysis Catheter

Teleflex Incorporated announced it has received FDA 510(k) clearance to market its ARROW® Triple Lumen Pressure Injectable Acute Hemodialysis Catheter. The ARROW® Triple Lumen Pressure Injectable Acute Hemodialysis Catheter is available in the ARROW® ErgoPack® System, helping hospitals maintain compliance with current vascular access guidelines and standards while providing maximal barrier protection against infections when inserting these lines. Teleflex is committed to partnering with healthcare facilities to reduce vascular access related complications. The ARROW® Triple Lumen Pressure Injectable Acute Hemodialysis Catheter is another example of the Teleflex commitment to this goal.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TFX:US $126.11 USD -0.51

TFX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hill-Rom Holdings Inc $53.25 USD -0.50
IDEXX Laboratories Inc $73.11 USD -2.10
PerkinElmer Inc $47.88 USD -0.33
STERIS Corp $66.47 USD -0.71
Cooper Cos Inc/The $139.87 USD +0.68
View Industry Companies

Industry Analysis


Industry Average

Valuation TFX Industry Range
Price/Earnings 31.2x
Price/Sales 2.9x
Price/Book 2.7x
Price/Cash Flow 27.8x
TEV/Sales 2.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TELEFLEX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at